SGS Pharma
SGS Pharma Clinical Research is a leading CRO (contract service organization) offering clinical research and bioanalytical testing with a specific focus on early stage development and biometrics (phase I to IV).
Locations
- APAC
- Europe
- North America
Therapeutic Areas
- Bone / Osteoporosis
- Cardiovascular
- CNS
- Dermatology
- Diabetes
- Endocrinology
- Gastroenterology
- Genetic Diseases
- Hematology
- Hepatology
- Immunology
- Infectious Diseases
- Inflammation
- Internal Diseases
- Metabolic Diseases
- Musculoskeletal
- Nephrology
- Neurology
- Nutrition and Health
- Obstetrics / Gynecology
- Oncology
- Ophthalmology
- Other
- Pediatrics / Neonatology
- Pharmacology / Toxicology
- Psychiatry
- Pulmonary
- Rare Disease
- Respiratory
- Rheumatology
- Thrombosis
- Urology
- Vaccines
- Women's Health
SGS Pharma Clinical Research is a leading CRO specializing in early-stage development and functional biometrics (Phases I–IV).
With a strong presence in Europe and the Americas, SGS offers a comprehensive range of clinical trial services, including full early-phase drug development consultancy, clinical project management and monitoring, biometrics, as well as medical safety and regulatory services.
SGS operates its own clinical pharmacology unit in Belgium featuring a viral challenge testing facility and a phase I patient unit based in Hungary. SGS has a wealth of expertise in FIH studies, viral challenge testing, biosimilars and complex PK/PD studies with a strong therapeutic focus on Infectious Diseases, Vaccines, Respiratory, Dermatology and Oncology.